Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS is your business.

Sydney Rosen1, Jonathon Simon, Jeffrey R Vincent

  • 1Boston University School of Public Health's Center for International Health, USA.

Harvard Business Review
|February 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the sustainability of Rwanda's mass drug administration program for schistosomiasis and soil-transmitted helminthiasis: A mixed-methods application of the program sustainability assessment tool.

PLoS neglected tropical diseases·2026
Same author

Quantification of macrophage activity in knee synovial tissue using [<sup>18</sup>F]FEPPA positron emission tomography.

Osteoarthritis imaging·2026
Same author

Facility-level integration of hypertension and diabetes services with HIV treatment in sub-Saharan Africa: Observational evidence from Malawi, South Africa, and Zambia.

PloS one·2026
Same author

Who does tracing work for? Characteristics of clients successfully re-engaged in ART care in sub-Saharan Africa after a tracing intervention: A systematic review.

PLOS global public health·2026
Same author

Genomic analysis of <i>Klebsiella pneumoniae</i> causing community-acquired respiratory deaths among Zambian infants and children using targeted RNA-probe hybridization-capture metagenomics.

bioRxiv : the preprint server for biology·2026
Same author

Age, sex-and what else? Rethinking priorities to close gaps in the HIV care cascade.

Journal of the International AIDS Society·2026

Investing in HIV/AIDS prevention and treatment programs is profitable for businesses operating in affected developing countries. These programs offer significant financial returns, making fighting the epidemic good business sense.

Area of Science:

  • Business Management
  • Epidemiology
  • Public Health

Background:

  • The global spread of Acquired Immunodeficiency Syndrome (AIDS) impacts developing economies by undermining globalization strategies reliant on cheap labor and growing markets.
  • The epidemic is rapidly expanding in regions beyond Africa, including Russia, Ukraine, China, and India, posing significant business risks.

Purpose of the Study:

  • To analyze the financial implications of HIV/AIDS on businesses in developing countries.
  • To evaluate the economic viability of corporate investments in HIV/AIDS prevention and treatment programs.

Main Methods:

  • Financial modeling was used to calculate the present value of epidemic-related costs, considering the long latency period of HIV infection.
  • Analysis of annual AIDS costs as a percentage of the wage bill for six corporations in South Africa and Botswana.

Related Experiment Videos

  • Simulation of investment returns from providing employees with highly active antiretroviral therapy (HAART).

    • Main Results:

    • Annual costs of AIDS to surveyed corporations ranged from 0.4% to 5.9% of their wage bills.
    • Mathematical models indicated that providing free HAART to employees would yield positive investment returns for all six companies.
    • Implementing treatment programs could reduce the 'AIDS tax' by up to 40.4% annually.

    Conclusions:

    • Corporate investment in HIV/AIDS prevention and treatment programs is financially beneficial, leading to cost savings that exceed program expenses.
    • Addressing the HIV/AIDS epidemic through business initiatives not only aids infected individuals but also strengthens corporate financial health.
    • Proactive management of HIV/AIDS is essential for businesses operating in or exposed to high-prevalence regions.